Congenital obstructive uropathy: Its origin and contribution to end-stage renal disease in children

Advances in Renal Replacement Therapy

Volumn 8, Issue 3, 2001, Pages 157-163

  Woolf, Adrian S ^a   Thiruchelvam, Nikesh ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bladder; Development; End stage renal failure; Fetus; Metanephros; Obstructive uropathy; Posterior urethral valves; Transplantation

Indexed keywords

GROWTH FACTOR; TRANSCRIPTION FACTOR;

BLADDER DYSFUNCTION; CHILD; DECOMPRESSION SURGERY; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; KIDNEY DISEASE; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MICTURITION; OBSTRUCTIVE UROPATHY; PATHOGENESIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PRUNE BELLY SYNDROME; REVIEW; URETHRA MALFORMATION; URETHRA VALVE;

EID: 0034861795     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/jarr.2001.26348     Document Type: Article

References (75)

1. Report of the peidatric renal registry
2. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents
3. Development of human fetal kidney in obstructive uropathy: Correlations with ultrasonography and urine biochemistry
4. Developmental defects and cystic diseases of the kidney
5. Calcium and the kidney, hydronephrosis
6. Posterior urethral valves
7. Posterior urethral valves: Theoretical considerations on embryological development
8. Development of the kidney
9. The life of the human kidney before birth: Its secrets unfold
10. Primary, non-syndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous with a locus on chromosome 1
11. Mutations in the hepatocyte nuclear factor-1β gene are associated with familial hypoplastic glomerulocystic kidney disease
12. Posterior urethral valves in siblings
13. Genetic etiology of posterior urethral valves
14. Posterior urethral valves in patients with Down's syndrome
15. Terminal deletion of chromosome 10q at band 26.1: Follow-up in an adolescent male with high-output renal failure from congenital obstructive uropathy
16. Townes-Brockes syndrome and renal dysplasia: A novel mutation in the SALL1 gene
17. Homozygosity and linkage-disequilibrium mapping of the urofacial (Ochoa) syndrome gene to a 1-cM interval on chromosome 10q23-q24
18. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men
19. Angiotensin type 2 receptor is important in the normal development of the ureter
20. Prenatally detected posterior urethral valves: Is gestational age at detection a predictor of outcome?
21. Ultrasound diagnosis of posterior urethral valves in neonates
22. Antenatal diagnosis of posterior urethral valves
23. The mild end of the clinical spectrum of posterior urethral valves
24. Mercaptoacetlytriglycine (MAG3) renography and indirect radionulceide cystography in posterior urethral valves
25. Consensus on the prenatal management of antenatally detected urological abnormalities
26. Long-term outcome in children after antenatal intervention for obstructive uropathies
27. Percutaneous fetal cystoscopy and endoscopic fulguration of posterior urethral valves
28. Prognosis for patients with prenatally diagnosed urethral valves
29. Predictors of eventual end stage renal disease in children with posterior urethral valves
30. Use of urinary β-2 microglobulin to predict severe renal damage in fetal obstructive uropathy
31. Fetal serum β2-microglobulin predicts postnatal renal function in bilateral uropathies
32. The long-term outcome of posterior urethral valves treated with primary valve ablation and observation
33. Complications of posterior urethral valve surgery and their prevention
34. Increased sodium requirement following early postnatal surgical correction of congenital uropathies in infants
35. Progression to end-stage renal disease in children with posterior urethral valves
36. Growth in boys and posterior urethral valves. Primary valve resection versus upper tract diversion
37. Are valve bladders congenital or iatrogenic?
38. Comparative urodynamic findings after primary valve ablation, vesicostomy or proximal diversion
39. Long-term outcome of boys with posterior urethral valves
40. Influence of initial therapy on progression of renal failure and body growth in children with posterior urethral valves
41. The bladder in boys with posterior urethral valves: A urodynamic assessment
42. The urodynamic consequences of posterior urethral valves
43. Bladder dysfunction in boys with posterior urethral valves
44. The changing urodynamic pattern from infancy to adolescence in boys with posterior urethral valves
45. Peristent polyuria after posterior urethral valves
46. The outcome of renal transplantation in children with posterior urethral valves
47. Results of renal transplantation in boys treated for posterior urethral valves
48. Long-term results of renal transplantation into the valve bladder
49. Renal transplantation following renal failure due to urological disorders
50. Clinical course and outcome for children with multicystic dysplastic kidneys
51. Unilateral renal agenesis may result from in utero regression of multicystic renal dysplasia
52. Prune belly syndrome: Clinicopathologic study of 29 cases
53. Prostate development in prune belly syndrome (PBS) and posterior urethral valves (PUV); etiology of PBS - Lower urinary tract obstruction or primary mesenchymal defect?
54. Fetal bilateral obstructive uropathy: A series of nine cases
55. Postnatal management of antenatally detected, bilateral hydronephrosis
56. Clinical outcome and management of prenatally diagnosed primary megaureters
57. Prenatal bladder outlet obstruction secondary to ureterocele
58. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations
59. Deregulation of cell survival in cystic and dysplastic renal development
60. Fetal obstructive uropathy: Patterns of renal pathology
61. Expression of hepatocyte growth factor/scatter factor and its receptor, MET, suggests roles in human embryonic organogenesis
62. Insulinlike growth factor (IGF) and IGF binding protein gene expression in multicystic renal dysplasia
63. Inflammatory mediators in human renal dysplasia
64. Potential biological role of transforming growth factor-β1 in human congenital kidney malformations
65. Fetal urinary insulin-like growth factor I and binding protein 3 in bilateral obstructive uropathies
66. Increased urinary transforming growth factor-β1 excretion in children with posterior urethral valves
67. The response of the fetal kidney to obstruction
68. Experimental bilateral urinary obstruction in fetal sheep: Transforming growth factor-β1 expression
69. Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys
70. Deregulation of renal transforming growth factor-β1 after short-term experimental ureteric obstruction in fetal sheep
71. Cell proliferation, apoptosis, Bcl-2 and Bax expression in obstructed opossum early metanephroi
72. Insulin-like growth factor improves renal architecture of fetal kidneys with complete ureteric obstruction
73. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor
74. Correction of congenital hydronephrosis in utero IV: In utero decompression prevents renal dysplasia
75. Recovery following relief of unilateral obstruction in the neonatal rat